Cited 1 times in
Mitral and Aortic Regurgitation in Patients Undergoing Kidney Transplantation: The Natural Course and Factors Associated With Progression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김대영 | - |
dc.contributor.author | 서지원 | - |
dc.contributor.author | 심지영 | - |
dc.contributor.author | 이주한 | - |
dc.contributor.author | 조익성 | - |
dc.contributor.author | 하종원 | - |
dc.contributor.author | 허규하 | - |
dc.contributor.author | 홍그루 | - |
dc.date.accessioned | 2022-03-11T06:18:27Z | - |
dc.date.available | 2022-03-11T06:18:27Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/188028 | - |
dc.description.abstract | Background: Valve regurgitation can decrease with resolution of hemodynamic loads on the left ventricle (LV) after kidney transplantation (KT). We aimed to investigate the natural course of left-side valve regurgitation after KT and factors associated with progression. Methods: Among patients who underwent KT in two tertiary centers, 430 (224 men, mean age 50 ± 13 years) were examined by echocardiography within 3 months before KT and between 6 and 36 months after KT. Mitral regurgitation (MR) and aortic regurgitation (AR) were graded according to the current guidelines. Regression was defined as a decrease in regurgitation by one or more steps, and progression was an increase in one or more steps after KT. Clinical and echocardiographic factors associated with progression of MR and AR were analyzed. Results: Mild or greater MR was observed in 216 (50%) patients before KT, and mild or greater AR was observed in 99 (23%). During the follow-up period of 23.4 ± 9.9 months, most patients experienced regression or no change in regurgitation after KT, but 34 patients (7.9%) showed MR progression and 37 (8.6%) revealed AR progression. Patients who showed MR progression were more likely to receive a second KT, have mitral annular calcifications, and show a smaller decrease in LV end-systolic dimension. Patients who showed AR progression were more likely to have persistent hypertension after KT, aortic valve calcifications, and a smaller reduction of LV end-systolic dimension. Conclusions: Risk factors for progression of MR after KT include a second KT, MAC and a smaller decrease in LV end-systolic dimension after KT. Risk factors for progression of AR include valve calcification, persistent hypertension and a smaller decrease in LV end-systolic dimension after KT. Further echocardiographic surveillance and risk factor management after KT are warranted in these patients. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Frontiers Media S.A. | - |
dc.relation.isPartOf | FRONTIERS IN CARDIOVASCULAR MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Mitral and Aortic Regurgitation in Patients Undergoing Kidney Transplantation: The Natural Course and Factors Associated With Progression | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Minjeong Kim | - |
dc.contributor.googleauthor | Darae Kim | - |
dc.contributor.googleauthor | Juhan Lee | - |
dc.contributor.googleauthor | Dae-Young Kim | - |
dc.contributor.googleauthor | Jiwon Seo | - |
dc.contributor.googleauthor | Iksung Cho | - |
dc.contributor.googleauthor | Kyu Ha Huh | - |
dc.contributor.googleauthor | Geu-Ru Hong | - |
dc.contributor.googleauthor | Jong-Won Ha | - |
dc.contributor.googleauthor | Chi Young Shim | - |
dc.identifier.doi | 10.3389/fcvm.2022.809707 | - |
dc.contributor.localId | A05995 | - |
dc.contributor.localId | A01913 | - |
dc.contributor.localId | A02213 | - |
dc.contributor.localId | A03163 | - |
dc.contributor.localId | A03888 | - |
dc.contributor.localId | A04257 | - |
dc.contributor.localId | A04344 | - |
dc.contributor.localId | A04386 | - |
dc.relation.journalcode | J04002 | - |
dc.identifier.eissn | 2297-055X | - |
dc.identifier.pmid | 35155633 | - |
dc.subject.keyword | ESRD | - |
dc.subject.keyword | aortic regurgitation | - |
dc.subject.keyword | kidney transplantation | - |
dc.subject.keyword | left-side valve disease | - |
dc.subject.keyword | mitral regurgitation | - |
dc.contributor.alternativeName | Kim, Dae-Young | - |
dc.contributor.affiliatedAuthor | 김대영 | - |
dc.contributor.affiliatedAuthor | 서지원 | - |
dc.contributor.affiliatedAuthor | 심지영 | - |
dc.contributor.affiliatedAuthor | 이주한 | - |
dc.contributor.affiliatedAuthor | 조익성 | - |
dc.contributor.affiliatedAuthor | 하종원 | - |
dc.contributor.affiliatedAuthor | 허규하 | - |
dc.contributor.affiliatedAuthor | 홍그루 | - |
dc.citation.volume | 9 | - |
dc.citation.startPage | 809707 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN CARDIOVASCULAR MEDICINE, Vol.9 : 809707, 2022-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.